Variation in the Diagnostic Evaluation among Persons with Hematuria: Influence of Gender, Race and Risk Factors for Bladder Cancer
Jacob Ark(Vanderbilt University Medical Center), Daniel A. Barocas(Vanderbilt University Medical Center), Michael T. Mumma(International Epidemiology Institute), Tatsuki Koyama(Vanderbilt University Medical Center), Jeffrey C. Bassett(Vanderbilt University Medical Center), Chaochen You(Vanderbilt University Medical Center), JoAnn Alvarez(University of Bonn), David F. Penson(Geriatric Research Education and Clinical Center), Matthew J. Resnick(Vanderbilt University Medical Center), William J. Blot(Shanghai Cancer Institute)
Cited by 33
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656